Actimus Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.50 Cr
as on 17-07-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.35 Cr
as on 17-07-2024
- Revenue 7.66%
(FY 2022)
- Profit 9.77%
(FY 2022)
- Ebitda -23.35%
(FY 2022)
- Net Worth 12.77%
(FY 2022)
- Total Assets -6.15%
(FY 2022)
About Actimus Biosciences
The Corporate was formerly known as Tavisa Biosciences Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr.
The company has closed loans amounting to ₹5.35 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ajjagottu Ramanathareddy, Devadi Rao, and Devadi Kumar serve as directors at the Company.
- CIN/LLPIN
U74140AP2004PTC042512
- Company No.
042512
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Actimus Biosciences Private Limited offer?
Actimus Biosciences Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Research and Development (R&D) Work, Product Development Research, Copywriting & Content Development, Content Writing Service.
Who are the key members and board of directors at Actimus Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajjagottu Ramanathareddy  | Managing Director | 28-Jan-2004 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devadi Rao | Director | Current | |
| Devadi Kumar | Additional Director | 16-Feb-2022 | Current |
Financial Performance of Actimus Biosciences.
Actimus Biosciences Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.66% increase. The company also saw a slight improvement in profitability, with a 9.77% increase in profit. The company's net worth Soared by an impressive increase of 12.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Actimus Biosciences?
In 2022, Actimus Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 01 Oct 2015 | ₹3.50 Cr | Satisfied |
State Bank Of India Creation Date: 16 Apr 2011 | ₹8.50 M | Satisfied |
State Bank Of India Creation Date: 18 Nov 2008 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Actimus Biosciences?
Actimus Biosciences has a workforce of 273 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Actimus Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actimus Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
